Why the study?
CVD remains the leading cause of morbidity and mortality in Malaysia, driven by the rising prevalence of risk factors, prompting the need to investigate the prevalence of CVD and its associated risk factors in the community.
The MyHEBAT study protocol describes a nationwide initiative to evaluate the prevalence of cardiovascular disease, associated risk factors, and familial hypercholesterolemia in the Malaysian community.
Highlights high CVD risk factor burden in Malaysia; leaves open need for targeted interventions pending prospective data.
Cardiovascular disease (CVD) has been a burden to many developing countries for decades, including Malaysia. Although various steps have been taken to prevent and manage CVD, it remains the leading cause of morbidity and mortality. The rising prevalence of CVD risk factors such as hypertension, hypercholesterolaemia, diabetes, overweight and obesity is the main driving force behind the CVD epidemic. Therefore, a nationwide health study coined as the Malaysian Health and Wellbeing Assessment (MyHEBAT) was designed. It aimed to investigate the prevalence of CVD and the associated risk factors in the community across Malaysia. The MyHEBAT study recruited participants (18-75 years old) through community health screening programmes from 11 states in Malaysia. The MyHEBAT study was further divided into two sub-studies, namely, the Cardiovascular Risk Epidemiological Study (MyHEBAT-CRES) and the MyHEBAT Familial Hypercholesterolaemia Study (MyHEBAT-FH). These studies assessed the prevalence of CVD risk factors and the prevalence of FH in the community, respectively. The data garnered from the MyHEBAT study will provide information for healthcare providers to devise better prevention and clinical practice guidelines for managing CVD in Malaysia.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: